Skip to content

A randomized clinical trial to Comparison of the effectiveness of two contingency management therapies and transtheoretical model on sexual risk behavior in Cocaine consumers

A randomized clinical trial to Comparison of the effectiveness of two contingency management therapies and transtheoretical model on sexual risk behavior in Cocaine consumers

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20190218003
Enrollment
Unknown
Registered
2019-02-18
Start date
2014-12-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

It is suggested that consideration be given to savings on potential costs in contingency management in future studies. Contingency Management (CM)&#44

Interventions

Transtheoretical model (TTM) can be considered as a cognitive and motivational view&#44
a component which plays a significant role in addiction. ,The experimental group received a 12&#45
week contingency management treatment protocol and change based on stages treatment with an awareness&#45
raising approach to the health consequences of high risky sexual behavior in the form of a brochure as weekly one&#45
hour sessions and the control group was placed on the waiting list.
Experimental Biological/Vaccine,Placebo Comparator Behavioral
Transtheoretical model (TTM) ,contingency management (CM)

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria included the age range of 18-60 years old, the minimum ability to read and write, the history of addiction between 2 to 10 years, and the rate of consumption between 0.3 to 1 grams per day by smoking and housing in Tehran and the suburbs with deviations Maximum 30 sq. Km;

Exclusion criteria

Exclusion criteria: Exclusion criteria also included concurrent drug dependence, history of specific diseases or severe psychiatric disorders, use of neuroleptic drugs, absence of more than two sessions in the treatment process and failure to complete the informed consent form.

Design outcomes

Primary

MeasureTime frame
using condoms 12 weeks The sexual behavior questionnaire

Secondary

MeasureTime frame
follow-up results 12 weeks The sexual behavior questionnaire

Countries

iran

Contacts

Public Contactbijan pirnia

Bijan Center for Substance Abuse Treatment, tehran, iran

b.pirnia@usc.ac.ir+9802122081450

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026